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The immediate early gene product Arc (activity-regulated
cytoskeleton-associated protein) is posited as a master regulator
of long-term synaptic plasticity and memory. However, the
physicochemical and structural properties of Arc have not
been elucidated. In the present study, we expressed and
purified recombinant human Arc (hArc) and performed the first
biochemical and biophysical analysis of hArc’s structure and
stability. Limited proteolysis assays and MS analysis indicate
that hArc has two major domains on either side of a central
more disordered linker region, consistent with in silico structure
predictions. hArc’s secondary structure was estimated using CD,
and stability was analysed by CD-monitored thermal denaturation
and differential scanning fluorimetry (DSF). Oligomerization
states under different conditions were studied by dynamic light
scattering (DLS) and visualized by AFM and EM. Biophysical
analyses show that hArc is a modular protein with defined
secondary structure and loose tertiary structure. hArc appears
to be pyramid-shaped as a monomer and is capable of reversible
self-association, forming large soluble oligomers. The N-terminal
domain of hArc is highly basic, which may promote interaction
with cytoskeletal structures or other polyanionic surfaces, whereas
the C-terminal domain is acidic and stabilized by ionic conditions
that promote oligomerization. Upon binding of presenilin-1 (PS1)
peptide, hArc undergoes a large structural change. A non-
synonymous genetic variant of hArc (V231G) showed properties
similar to the wild-type (WT) protein. We conclude that hArc
is a flexible multi-domain protein that exists in monomeric and
oligomeric forms, compatible with a diverse, hub-like role in
plasticity-related processes.
Key words: Arc, biophysical characterization, oligomerization,
presenilin-1, protein purification, protein stability, synaptic
plasticity.
INTRODUCTION
Storage of information in the brain is thought to require the
plasticity of neural circuits. Stable forms of synaptic plasticity
have long been known to depend on neuronal activity-induced
protein synthesis [1,2]. The immediate early gene product,
activity-regulated cytoskeleton-associated protein (Arc/Arg3.1),
has emerged as a key protein in memory formation and diverse
types of synaptic plasticity including long-term potentiation
(LTP), long-term depression (LTD) and homoeostatic synaptic
scaling [3–6]
In the first papers describing Arc, the authors reported 20%
sequence similarity between a C-terminal region of Arc (rat amino
acids 228–380 of 396) and two α-spectrin repeats [7,8]. Spectrin
repeats are diverse and co-ordinate cytoskeletal interactions and
can serve as a ‘switchboard’ for interactions with multiple
proteins [9]. Arc in fact binds to a nuclear spectrin isoform,
βSpIV5, in promyelocytic leukaemia (PML) bodies in the
nucleus [10]. A recent study shows that nuclear Arc functions
to decrease transcription of the AMPA (α-amino-3-hydroxy-
5-methyl isoxazole-4-propionic acid)-type glutamate receptor
subunit GluA1, resulting in a homoeostatic downscaling of
excitatory synaptic transmission [11]. At synapses, Arc interacts
with components of the clathrin-mediated endocytosis machinery,
endophilin-3 and dynamin-2, to promote internalization of
AMPA receptors and LTD [12,13]. Arc also recruits presenilin-
1 (PS1) and the γ -secretase complex to endosomes, resulting
in enhanced processing of amyloid precursor protein (APP)
and Notch1 [14,15]. Arc protein synthesis is critical in the
consolidation phase of LTP [16–19], a process that also requires
actin cytoskeletal remodelling in dendritic spines [20,21]. During
LTP, Arc promotes filamentous actin (F-actin) stabilization
and phosphorylation of the actin-binding protein cofilin [17].
Furthermore, Arc has been suggested to interact with newly
polymerized microtubules [22].
Taken together, evidence suggests that Arc interacts with
several distinct proteins to regulate multiple cellular processes.
Despite 20 years of research on Arc, little is known about the
basic properties of the protein with regard to its structure and
stability. Such information is essential if we are to gain a molecular
understanding of Arc function in synaptic plasticity and cognition.
In the present work, we have expressed and purified recombinant
human Arc (hArc) and we have characterized the protein by
using a number of complementary biochemical, biophysical
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and microscopy analyses. The results indicate that hArc is a
flexible protein consisting of two major domains on either side of
a central, mostly unstructured, hinge region. Furthermore, we
show that hArc is monomeric and capable of reversible self-
oligomerization. The N-terminal domain is highly basic and
stabilized by heparin, whereas the C-terminal domain is acidic
and stabilized by increasing salt concentration. The stabilization
of the Arc C-terminal domain is associated with oligomerization.
Furthermore, we show that a peptide corresponding to the N-
terminal cytoplasmic region of the hArc partner PS1 [14] binds
to hArc and rearranges its conformation. These findings indicate
that hArc is a flexible multi-domain protein capable of reversible
self-oligomerization.
The 1000 Genomes Project [23] uncovered a single non-
synonymous ARC variant, which results in an amino acid
substitution of glycine for valine at position 231 (rs201562490).
The V231G polymorphism is present in around 2–4.6% of the
population and to the best of our knowledge no phenotypic
characterization has been reported. In the present study, we
demonstrate that V231G hArc has similar structural properties
as the wild-type (WT) hArc protein.
MATERIALS AND METHODS
In silico Arc analysis
A multiple sequence alignment was performed using Clustal
Omega software [24] and viewed in Jalview 2 [25]. Consensus was
calculated based on an algorithm analysing the physicochemical
properties of sets of amino acids in the multiple sequence
alignment [26]. MeDor, a meta-predictor of protein structure [27],
was used to analyse the primary hArc sequence. MeDor outputs
graphical displays of various prediction methods including a
hydrophobic cluster analysis (HCA) plot [28]. Horizontal clusters
indicate α-helices and vertical shapes mainly correspond to β-
strands. Publicly available structure models of hArc were obtained
from MODBASE [29], which contains theoretically calculated
models based on homology. Reliability was measured using five
different methods with the following thresholds; MPQS (ModPipe
Quality Score): 1.1, TSVMod NO35 [estimated native overlap at
3.5 Å (1 Å = 0.1 nm)]: 40%, GA341: 0.7, E-value: <0.0001,
zDOPE: <0.
Preparation of recombinant human Arc
The Arc coding sequence of hArc was amplified by
PCR from a cDNA library using the primers 5′-GCTT-
CCATGGAGCTGGACCACC-3′ and 5′-GCTTGGTACC-
CTACTCGGGCTGG-3′ (the NcoI and Acc65I restriction sites
are underlined). The PCR product was ligated into pETMBP_1a
[maltose-binding protein (MBP)], pETZZ_1a, pETTrx_1a
[thioredoxin (Trx)] and pETGST_1a [30]. The resulting
constructs were transformed into One Shot® TOP10 Chemically
Competent Cells (Invitrogen). Plasmids were sequenced before
being transformed into BL21-CodonPlus Competent Cells
(Agilent) for protein expression.
A pilot expression and purification study was performed to test
expression from each of the plasmids in 2 ml of auto-induction
medium [31]. Cultures were incubated with vigorous shaking
at 27 ◦C overnight, harvested, resuspended in 10 ml/g lysis buffer
(20 ml Tris/HCl, pH 7.4, 10 mM imidazole, 150 mM NaCl, 0.2%
NP-40, 10 mM mercaptoethanol and 10% glycerol), sonicated
and centrifuged again. The supernatant was pressed through
0.45 μm pore size filters and loaded on to columns of 30–50 μl
of Ni-NTA (Ni2+-nitrilotriacetate)–agarose resin (Qiagen). The
resin was sequentially washed with the following buffers: (1)
lysis buffer, (2) lysis buffer without NP-40, (3) wash number 2
with 1 M NaCl, and (4) wash number 2 with 40 mM imidazole.
Bound protein was eluted with 330 mM imidazole. Most of the
experiments in the present work were performed using hArc
cleaved from the His–ZZ–hArc fusion protein, and for upscaled
pET ZZ_1a-hArc cultures, ∼4 ml of Ni–NTA–agarose (Qiagen)
was used.
The His–ZZ expression tag was completely cleaved off by
adding 1:100 (w/w ratio) His-tagged TEV (tobacco etch virus)
protease directly to the dilute eluate from the affinity column
and left to incubate for 12 h at 4 ◦C. After incubation, the
volume was reduced to 2.5 ml using 30 kDa cut-off centrifuge
filters (Vivaspin) and buffer-exchanged to 20 mM Tris/HCl,
pH 7.4, 150 mM NaCl and 10 mM mercaptoethanol, using PD-
10 Desalting Columns (GE Healthcare) to remove imidazole.
The eluate was loaded on columns of 30–50 μl of Ni-NTA–
agarose to remove the His–ZZ tag and His-tagged TEV. The flow-
through (containing pure hArc protein, either WT or V231G hArc
variant) was collected. The GST–hArc fusion protein, purified by
glutathione-Sepharose 4B (GE Healthcare Life Sciences), was
used when indicated.
Site-directed mutagenesis of pET ZZ_1a-hArc was performed
using the QuikChange SDM kit (Stratagene) according
to the manufacturer’s protocol (primers: 5′-TACTTGC-
GGCAGGGGGGCGGC TCTGAGG-3′ and 5′-CATGAACGC-
CGTCCCCCC GCCGAGACTC-3′; mutated bases are under-
lined). Mutagenesis was confirmed by DNA sequencing. The
protein was then purified as described above.
Buffer exchange to the conditions specific in each experiment
was performed by running the samples through Zeba Spin
Desalting Columns (Thermo Scientific) using the manufacturer’s
protocol.
Cell culture
Human SH-SY5Y cells (A.T.C.C.) were grown in Dulbecco’s
modified Eagle medium (DMEM; Sigma) supplemented with
10% FBS, penicillin/streptomycin and L-glutamine. Cells were
lysed in PBS containing 0.1% Triton-X100, 1 mM PMSF and
Roche Complete Protease Inhibitor Cocktail.
SDS/PAGE and immunoblot analysis
Protein (40 μg) was separated on SDS/PAGE (10 % gel)
and transferred on to a nitrocellulose membrane (Hybond-C).
Membranes were blocked for 1 h at room temperature (RT) in
TBST (Tris-buffered saline/0.1% Tween 20) and 3% non-fat
dried milk. Arc C-7 primary antibody (Santa Cruz Biotechnology)
was diluted in blocking buffer containing TBST and 5% BSA and
applied on membranes overnight at 4 ◦C with constant shaking.
Following three washes with TBST, blots were incubated for 1 h
at RT in horseradish peroxidase-conjugated secondary antibody
diluted in TBST. Blots were then visualized using ECL (Pierce,
ECL Western Blotting Substrate).
Limited proteolysis
Aliquots of 13 μg of hArc were individually digested with either
trypsin or chymotrypsin. Both proteases were prepared using
25 mM sodium Hepes (pH 7.4) buffer. Proteolytic digestions were
performed on ice with protease/hArc ratios of 1:100, 1:1000,
1:10000 and 1:100000. The reactions were stopped by adding
2 μl of protease inhibitor solution (1 Roche Complete Protease
Inhibitor Cocktail tablet in 500 μl of 25 mM sodium Hepes,
pH 7.4) at different time points. Ten microlitres of the reaction
products was loaded on a SDS/PAGE (15 % gel). Chymotrypsin
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was chosen for further analyses at a protease/hArc ratio of 1:100.
The process was repeated over a time course of 120 min and the
appearance of fragments was visualized by SDS/PAGE. MS was
performed on both chymotrypsin and trypsin digestion fragments.
MS
Digestion bands were cut from the gel with a clean scalpel.
Gel pieces were then cut into 1-mm cubes followed by in-gel
hydrolysis. The gel pieces were washed, reduced using DTT
and alkylated with iodacetamide. The dehydrated gel pieces
were transferred to glass tubes (300 μl) and 20–30 μl of 3 M
HCl was added and the tubes were microwaved for 10 min
at 900 W. The supernatant was removed and desalted directly
on Oasis HLB Elution Plate (Waters). Samples were eluted in
50 μl, dried in a speed vacuum centrifuge and dissolved in
10 μl of reconstitution buffer (96:4 water/acetonitrile and 0.1%
formic acid) and analysed by LC–MS/MS. Here, peptides were
separated using the nanoAcquity UPLC system (Waters) fitted
with a trapping (nanoAcquity Symmetry C18, 5 μm, 180 μm ×
20 mm) and analytical column (nanoAcquity BEH C18, 1.7 μm,
75 μm × 200 mm) coupled directly to an linear trap quadropole
(LTQ) Orbitrap Velos (Thermo Fisher Scientific) with a Proxeon
nanospray source. Solvent A was water + 0.1% formic acid
and solvent B was acetonitrile + 0.1% formic acid. The
samples (8 μl) were loaded with a constant flow of solvent A at
5 μl/min on to the trapping column. Peptides were eluted via the
analytical column at a constant flow of 0.3 μl/min. The peptides
were introduced into the mass spectrometer (Orbitrap Velos Pro,
Thermo) via a Pico-Tip Emitter 360 μm OD (outer diameter) ×
20 μm ID (inner diameter); 10 μm tip (New Objective) and a
spray of 2.2 kV was applied. Full scan MS spectra with mass
ranges of 300–1700 m/z were acquired in the fourier transform
(FT) profile mode with resolution of 30000. The most intense ions
(up to 15) from the full scan MS were selected for sequencing
in the LTQ. MS/MS data were acquired in centroid mode. Only
multiply charged precursor ions (2 + , 3 + , 4 + ) were selected
for MS/MS.
Data analysis was performed using MaxQuant Software
(version 1.0.13.13) for filtering the data and creating .mgf
files, needed for searching in MASCOT version 2.2.03
(Matrix Science). The data were searched against a species-
specific (Homo sapiens) Uniprot database with a list of
common contaminants appended. The data were searched with
the following modifications: carbamidomethyl (C; fixed) and
oxidation (M; variable). Termini were postulated based on peptide
ladders of increasing amino acid length, either all starting or all
ending at the same residue (for N- and C-termini respectively).
CD
Far-UV and thermal denaturation CD measurements were
performed with a J-810 Jasco spectropolarimeter equipped with
a CDF-426S Peltier element for temperature control using a
quartz cell with a path length of 1 mm. The buffer containing
purified hArc was exchanged using Zeba Spin Desalting Columns
with 10 mM potassium phosphate with various pHs, potassium
fluoride (KF) concentrations or additives such as heparin (Abbott
Laboratories) and calcium [added as Ca(NO3)2], as indicated.
The final protein concentration was 4.4 μM or 4.0 μM when
testing in the presence of 10 μM of a 40-residue peptide
corresponding to the cytoplasmic N-terminal region of PS1 (from
Tag Copenhagen). Spectra were acquired in the 185–260 nm
range at a scan rate of 50 nm/min at 20 ◦C. Two scans were
accumulated for each spectrum and three spectra were buffer-
subtracted and averaged. Thermal denaturation profiles were
obtained by recording the ellipticity at 222 nm as a function of
temperature in the range 4–100 ◦C with a scan rate of 2 ◦C/min.
The far-UV CD spectra and thermal denaturation profiles were
smoothed using a negative exponential algorithm with a sample
proportion = 0.05 and polynomial degree = 1. Circular dichroism
by neural networks (CDNN) [32] was used to estimate the
secondary structure content.
Differential scanning fluorimetry
Samples with 2 μM hArc were prepared in 20 mM sodium
Hepes, pH 7.0, with 5× SYPRO Orange (Sigma–Aldrich) with
or without 150 mM KF and added to wells in a 96-well plate
with decreasing concentrations of heparin (25 μg/ml to 0 μg/ml).
The plates were loaded into a Light Cycler 480 (Roche Applied
Science) and heated from 20 ◦C to 90 ◦C at a scan rate of
2 ◦C/min. Unfolding was monitored by following the increase
in SYPRO Orange fluorescence (λex = 465 nm, λem = 610 nm).
Half-denaturation temperature values (Tm values) were obtained
from the maximum first derivative of the raw data.
Dynamic light scattering
Dynamic light scattering (DLS) was performed on a Malvern
Zetasizer Nano ZS with a HeNe laser at 633 nm. Temperature
scans and size measurements were carried out at a fixed scattering
angle of 173◦ (back scatter). Temperature scans were run from
4 ◦C to 90 ◦C at a rate of 2 ◦C/min. Purified protein preparations
were diluted to 1 mg/ml (22 μM) in the indicated buffers and
additives. Data analysis was performed on intensity and volume
size distribution curves and the molecular mass and Z-average
size was calculated using Malvern DTS software. The intensity
size distribution, the first order result, is weighted according to
scattered intensity of each particle fraction whereas the volume
size distribution represents the relative proportion based on
the mass or volume, which is derived from the intensity size
distribution via the Mie theory. The Z-average provides a reliable
measure of the mean size of the particle size distribution [33].
EM
Samples of hArc under different conditions (water; 20 mM
sodium Hepes, pH 7.0; 20 mM sodium Hepes, pH 7.0, with
125 mM KCl) were applied to glow-discharged carbon grids at
RT for 3 min, washed and then stained for 2 min with 2% (w/v)
uranyl acetate. Micrographs were recorded on a JEOL 1200EX-II
electron microscope operated at 100 kV on Kodak SO-163 film.
AFM imaging
Samples were prepared by spreading 50 μl of hArc (11.25 μg/ml;
0.25 μM) in 10 mM potassium phosphate, pH 7.4, on a freshly
cleaved mica surface (diameter 1.2 cm), incubated for 10 min
and gently washed with milliQ distilled water. When dried,
AFM imaging was carried out in air at RT. All images were
generated with the tapping mode (AC mode) on an MFP-3D-
BioTM atomic force microscope (Asylum research, an Oxford
Instruments company) using silicon cantilevers, AC240, from
Olympus with a typical spring constant of 2 N/m. Images were
captured with a resolution of 256 pixels × 256 pixels and the scan
rate was adjusted for each sample to a value between 0.5 and 1
Hz. At least three regions of the sample surface were investigated
to confirm homogeneity. All images were processed using IGOR
PRO (Wavemetrics).
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Surface plasmon resonance
Surface plasmon resonance (SPR) analyses were carried out at
25 ◦C using a Biacore 3000 instrument (GE Healthcare) with
HBS-EP (10 mM sodium Hepes, pH 7.4, 150 mM NaCl, 3 mM
EDTA and 0.005% surfactant P20) as running buffer. Anti-GST
antibody (GST Capture Kit, GE Healthcare) was immobilized
by amine coupling to a level of 9210 response units (RU) on to a
CM5 sensor chip (GE Healthcare) according to the manufacturer’s
instructions. GST–hArc fusion protein (3 μg/ml, 66 nM) was
reversibly captured at a flow rate of 30 μl/min and a 3-min
injection to a level of 280–320 RU. Interaction with PS1 was tested
by injecting a series of dilutions of the peptide (100–400 μM)
over the GST–hArc surfaces at a flow rate of 30 μl/min and a 2-
min injection. Peptide A (EQLTKCEVFRELKDLKGY; obtained
from CPC Scientific Inc.), corresponding to the N-terminal region
of α-lactalbumin, was treated in the same way as PS1 and
used as a negative control. Regeneration of anti-GST antibody
surfaces was accomplished with a 30 μl/min injection of 10 mM
glycine/HCl, pH 2.1, for 2 min. All data generated were subtracted
from the reference surface (no anti-GST antibody immobilized).
BIAevaluation software (Version 3.2; GE Healthcare) was used
for analysis of the sensorgrams. Dissociation constants (Kd) were
calculated by fitting the sensorgrams to a 1:1 Langmuir binding
model via non-linear regression analysis.
RESULTS
Prediction of hArc structure
To predict whether hArc is structured or contains disordered
domains, MeDor, a meta-predictor of protein unstructured regions
[27], was used to analyse the primary hArc sequence (Figure 1A).
The HCA plot generated by MeDor predicted a central disordered
region and smaller regions of disorder at the N- and C-termini.
HCA also indicated two major domains containing mostly α-
helices and a few β-strands between the regions of predicted
disorder. Other disorder predictors were in large agreement
with the HCA plot (Figure 1A, arrows below HCA plot). The
multiple sequence alignment (Figure 1B), together with the
order/disorder predictions (Figure 1A), revealed highly conserved
C-terminal residues ∼209–365 (87.6% sequence identity
among sequences shown in Figure 1B), which correspond to
the putative C-terminal domain. The smaller putative N-terminal
domain (residues ∼25 – 130) has a lower residue conservation
(53.7% sequence identity; Figure 1B). Whereas this N-terminal
domain is highly basic (computed isoelectric point (pI) = 9.6), the
larger C-terminal domain is acidic (computed pI = 4.8). The full-
length protein is slightly acidic (computed pI = 5.5).
Predicted structural models of the putative N-terminal domain
and the central linker region of hArc were obtained from
MODBASE [29], which contains theoretically calculated models
based on homology, whereas we modelled the C-terminal domain
using the structure of two repeats of chicken α-spectrin as template
(Supplementary Figure S1). Nevertheless, all structural templates
for Arc show very low sequence identity (<35%) such that
each of the domains and the resulting structural models are just
moderately reliable.
Preparation of recombinant hArc protein
To maximize the yield of soluble hArc protein, four different
pET expression vectors were tested, each producing hArc with
its N-terminal fused to a His-tagged partner protein. Ligation of
the hArc open reading frame into pET MBP_1a, pET ZZ_1a,
pET Trx_1a and pET GST_1a produces hArc with MBP, an
IgG-binding ZZ-domain, Trx and GST respectively. Recombinant
fusion proteins from all constructs were expressed in bacteria
by auto-induction medium, allowing direct comparison of the
expression level [31] (Supplementary Figure S2A). Since hArc
expression was highest with the ZZ-tag, the auto-induction culture
containing pET ZZ_1a–hArc was scaled up and hArc was purified
as done in the expression screening (Supplementary Figures S2B
and S2C). Similar yield and homogeneity was obtained for the
V231G hArc variant. Immunoblot analysis confirmed that hArc
was immunoreactive and the same size as endogenous hArc from
human SH-SY5Y neuroblastoma cells (Supplementary Figure
S2D).
Limited proteolysis of purified hArc shows a protein with two
domains
Limited proteolysis is often used in the identification of the
boundaries of structural domains within multi-domain proteins
and other proteins containing potentially unstructured regions.
The basis for this relies on the increased sensitivity to protease
digestion of unstructured regions. Under appropriate digestion
conditions, well-structured domains typically accumulate as
digestion products that can then be analysed by MS or other
methods. Full-length hArc was subjected to limited proteolysis
with trypsin and chymotrypsin and the reaction products were
analysed by SDS/PAGE. Digestion of hArc with trypsin resulted
in four fragments (32, 18, 12 and 8 kDa; Figure 2A) and
chymotrypsin resulted in two major fragments (27 and 18 kDa;
Figure 2A). A third 16-kDa band appeared after longer incubation
times, which accumulated up to 80 min (time course not shown).
The bands corresponding to the different degradation fragments
were excised from the gels and subjected to MS analysis
by LC–MS/MS after in-gel hydrolysis. The 27-kDa fragment
produced by chymotrypsin digestion was identified as the region
corresponding to hArc residues 173–379 (Figure 2B) with an
expected molecular mass of 27.3 kDa. The 18-kDa fragment
produced by chymotrypsin was identified as the N-terminal region
including residues 1–172, with an expected molecular mass of
19.6 kDa, which is consistent with the apparent molecular mass
estimated by SDS/PAGE. These fragments are consistent with
a predicted chymotrypsin cleavage site at residue Tyr172 in the
central region of hArc and are also in accordance with the apparent
molecular mass seen by SDS/PAGE analysis. The 16-kDa band
was not sufficiently abundant for MS analysis.
In agreement with these results, analysis of the trypsin digestion
products indicated the presence of two highly accessible trypsin
sites in the central region of the protein (residues 145 and 218;
Figure 2B). These data indicate that full-length hArc is composed
of two distinct N- and C-terminal domains separated by a highly
protease-sensitive and, probably, less structured central region.
Despite intense efforts, we were not able to purify isolated forms
of the domains in the required amounts for biophysical and
structural analyses.
Secondary structure and conformational stability of hArc
We analysed the secondary structure of recombinantly expressed
hArc by far-UV CD spectra under various conditions (Figures 3A
and 3B; Supplementary Figure S3). The CD spectrum of hArc
at neutral pH revealed two local minima at 208 and 222 nm,
which indicates a high α-helical content (Figure 3A, green line), in
accordance with the prediction of secondary structure by MeDor
(Figure 1) and by MODBASE (Supplementary Figure S1). The
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Figure 1 Schematic representation of hArc, with predicted secondary structure, functionally relevant regions and motifs, sequence alignment and domain
organization
(A) Prediction of secondary structure and disordered/ordered regions of hArc as estimated by MeDor [27]. At the topid, the predicted secondary structure. Below the primary sequence, an HCA
plot shows the predicted regions of order and disorder. Symbols are used to represent residues with important structural characteristics [Proline (), glycine (), threonine () and serine ()].
Four additional disorder predictors were used, namely IUPred [56], GlobPlot2 [57], DisEMBL [58] and FoldIndex [59]. Functionally significant regions of the Arc protein are shown below these
predictions. The Arc regions involved in binding of four of the known partners are indicated on top whereas regions involved in localization are indicated at the bottom. (B) Multiple sequence
alignment of Arc from various species was performed with Clustal Omega and displayed in Jalview. The conservation of residues is highlighted by shades of blue; the darker the colour, the more
conserved the residue [26]. The extent of conservation was also calculated based on physicochemical properties of amino acid sets, indicated in the yellow/brown histogram.
c© 2015 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted
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Figure 2 Limited proteolysis of hArc
(A) Limited proteolysis was carried out with either trypsin (Tr) or chymotrypsin (Ch) at the indicated protease/hArc ratio. Trypsin resulted in four fragments (32, 18, 12 and 8 kDa) and chymotrypsin
resulted in two major fragments (27 and 18 kDa) with a third 16-kDa band appearing after extended incubation periods. In, hArc input; St, standard. (B) Map of all potential hArc cleavage sites for
chymotrypsin and trypsin. MS/MS-identified cleavage sites are indicated in boxes.
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Figure 3 Far-UV CD and DSF analysis of hArc
(A and B) CD spectra of hArc (4.4 μM) in 10 mM potassium phosphate at (A) pH 5.2 (red), 6.8 (orange), 7.4 (green) and 8.2 (blue) at 20◦C and at pH 7.4 at 100◦C (burgundy); CD spectrum taken
at 20◦C after heating hArc to 100◦C is similar to that shown by the green line; and at (B) pH 7.4 (green), with 5 μg/ml heparin (burgundy) or 20 μM calcium (blue). Thermal scans are shown in
insets. (C and D) DSF experiments where 2 μM hArc was incubated with the indicated concentrations of heparin (units are μg/ml) and subjected to a thermal gradient from 20◦C to 90◦C in 20 mM
sodium Hepes, pH 7.0, without KF salt (C) and with 150 mM KF salt (D). The thermal denaturations monitored by SYPRO Orange fluorescence (λex = 465 nm, λem = 610 nm) are shown in the main
plots, whereas T m values obtained from the maximum first derivative of the data are shown in the insets.
protein was stable in neutral–basic pH but showed a large loss of
ellipticity at pH 5.2 (Figure 3A). In addition, remaining secondary
structure was observed even after heating to 100 ◦C (Figure 3A,
burgundy line). This partial denaturation appeared fully reversible
since the CD spectrum taken after cooling the sample to 20 ◦C
was similar to that obtained prior to heating (Figure 3A, green
line). CDNN analysis [32] of the CD spectrum of hArc at
pH 7.4 (20 ◦C) predicted an α-helical and β-sheet structure of
42.1 +− 0.3% and 12.8 +− 0.2% respectively. The spectrum of
the polymorphic variant V231G hArc, with a substitution in the
proposed C-terminal domain, was very similar to that of WT hArc
(Supplementary Figure S3A) with a slightly higher estimated α-
helical content (51.0 +− 0.4%).
We tested the effect of various ionic conditions and additions
on the CD spectrum of hArc, such as calcium, the polyanion
heparin and salt (KF). Heparin was added as a mimic of
abundant polyanions in neurons, including the negatively charged
plasma membrane, cytoskeletal proteins such as tubulin and
actin, RNA and DNA [34]. These polyanions have shown
chaperoning activity of interacting proteins in vitro [34]. None
of these additives significantly altered the CD-estimated content
of secondary structure of WT or V231G hArc variant (Figure 3B;
Supplementary Figure S3B; and results not shown).
We then investigated hArc stability by differential scanning
calorimetry (DSC), CD-monitored thermal denaturation and
DSF (differential scanning fluorimetry) under various conditions.
Whereas no distinct unfolding endotherm was observed by DSC
(results not shown), which indicated a loose tertiary structure,
thermal unfolding transitions were observed by both thermal CD
(insets in Figures 3A and 3B; Supplementary Figures S3A and
S3B) and DSF (Figures 3C and 3D). These melting transitions
were, however, remarkably broad and non-co-operative, also
pointing to a loose flexible tertiary structure. Thermal CD scans
at pH 7.4 showed two overlapping unfolding events, with a Tm
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Table 1 Midpoint denaturation temperatures (T m1 and T m2) for the melting
transitions of hArc, measured by thermal-dependent CD and derivatization
of the transitions
hArc (4.4 μM) was prepared in 10 mM potassium phosphate at the indicated pH and conditions.
Condition T m1 (◦C) T m2 (◦C)
pH 6.3 43.2 +− 0.9 75.0 +− 0.6
pH 7.4 46.4 +− 1.1 74.3 +− 0.2
pH 8.2 48.5 +− 0.1 73.8 +− 1.0
pH 7.4, 150 mM KF 43.0 +− 0.2 75.8 +− 1.5
pH 7.4, 300 mM KF 42.7 +− 0.4 77.6 +− 0.1
pH 7.4, 5 μg/ml heparin 53.0 +− 0.8 73.9 +− 0.5
pH 7.4, 20 μM calcium 46.5 +− 0.9 74.3 +− 0.5
of 46.4 +− 1.1 ◦C for the first transition and 74.3 +− 0.2 ◦C for the
second transition (Figure 3A inset; Table 1). The first transition
was stabilized with heparin and slightly destabilized by increasing
KF concentration, conditions that seem to exert opposite effects
on the second transition (Figure 3B, inset; Table 1). A low
concentration of calcium did not affect the corresponding Tm-
values (Figure 3B, inset; Table 1). Finally, V231G hArc also
manifested two transitions (Supplementary Figure S3A, inset)
and had similar Tm values to that of the WT protein.
Further investigations on the conformational stability were
performed by DSF, a sensitive technique that provides information
on the thermal denaturation transitions of proteins and detects
stabilizing ligand interactions [35,36]. Remarkably, only the first,
low Tm transition was detected by DSF, whereas the second
appears to be lost due to baseline decay and distortion associated
with aggregation of the protein following the unfolding of the
first domain (Figures 3C and 3D) [37]. The Tm value obtained
for this transition at pH 7.4 without salt (Tm = 37.2 +− 0.1 ◦C)
or with 150 mM KF (Tm = 38.6 +− 0.1 ◦C) was lower than
those obtained by thermal CD, notably in the absence of salt
(Table 1). Nonetheless, DSF experiments strongly supported the
stabilization of this first unfolding transition of hArc by heparin,
both in the absence (Figure 3C) and in the presence of 150 mM
KF salt (Figure 3D).
In agreement with the domain organization predicted from the
sequence analyses and alignments (Figure 1), the CD results
show an hArc protein with high amounts of α-helical structure
and indicate the presence of a modular organization with two
major domains and a loose, flexible tertiary structure. The more
stable domain (Tm about 74 ◦C at pH 7.4) is further stabilized
by KF and the domain with the lower Tm binds to and is
stabilized by heparin (Table 1), as also corroborated by DSF.
Based on the size of the domains (N-terminal residues 25–130,
C-terminal residues 209–365) as well as the distribution and
balance of charged residues [38], we predicted that the first and
second thermal transitions corresponded to the N-terminal and
C-terminal domains respectively. The fact that the N-terminal
domain of hArc (residues ∼25–130) was highly basic (pI = 9.6)
further corroborated this prediction, explaining its interaction
with and stabilization by heparin. Interestingly, the N-terminal
domain showed a high homology with human Janus kinase and
microtubule-interacting protein 1, also called Marlin-1 (27 %
sequence identity between residues 56–106 of hArc and 325–
375 of Marlin-1), with a remarkable co-distribution of positively
charged residues (Supplementary Figure S4). On the other hand,
our DSF results suggested a possible aggregation tendency of the
larger and more stable C-terminal domain and we investigated
this feature in more detail.
Oligomeric distribution of hArc
To further investigate the homogeneity and oligomeric state of
recombinant hArc under various conditions, DLS was carried
out. The plots for intensity size distribution revealed a unique
population with a hydrodynamic diameter (Dh) of 33.9 +− 8.0 nm
(22.6 +− 0.6 nm for volume size distribution) in 10 mM potassium
phosphate buffer, pH 7.4, at 36 ◦C. This size corresponds to
an estimated molecular mass of >552 kDa for a protein with
some elongation, indicating that under these conditions hArc is
an oligomer with >12 subunits. Populations with larger sizes
(approximately Dh = 45 nm) corresponding to large clusters of
self-associated hArc (40 subunits) were also observed at higher
and lower temperatures (90 ◦C and 20 ◦C respectively; Figure 4A).
As better seen in the volume size distribution (Figure 4A, inset),
another population of a smaller diameter (about 8.1–9.6 nm)
was also observed at 20 ◦C in buffer without salt. Moreover,
when hArc was prepared in double-distilled water, a smaller size
population was also observed (Dh = 5.7 nm), corresponding to
an estimated molecular mass of 48 kDa, i.e. monomeric hArc
(Figure 4A, inset). Thus, the species with Dh = 8.1–9.4 nm,
appearing in both water and buffer without salt might be either
dimers or monomeric forms of hArc with a very elongated shape.
The propensity to form large oligomers/aggregates (diameter
>43.8 nm) in a temperature-dependent manner (notably at
temperatures > 40 ◦C) increased with decreasing pH (Figure 4B)
and with increasing salt content (Figure 4C). The V231G hArc
polymorphism or the addition of calcium (results not shown) or
heparin (Figure 4D) did not affect the size distribution or thermal-
dependent aggregation propensity. Furthermore, the increased
propensity for oligomerization/aggregation in the presence of
salt was observed both with and without heparin (Figure 4D).
The hArc populations of different sizes were interconverted by
changing the buffer conditions. Oligomerization thus appeared
to be reversible. The experiments shown in Figure 4 were
all performed at a concentration of hArc of 1 mg/ml (22 μM
subunit) and, as expected from the Law of Mass Action, higher
concentrations exacerbated the oligomerization/aggregation of
the protein (results not shown).
A particular feature revealed by the DLS-monitored thermal
scans, under all conditions, was that recombinant hArc undergoes
oligomerization in the 4–30 ◦C range, which was reversible since
the thermal DLS was completed in the same sample in the 4–90 ◦C
range (Figures 4B and 4C).
Visualization of hArc by EM and AFM
As indicated by DLS experiments, hArc in water and a major
fraction of hArc in buffer of low ionic strength is monomeric.
Thus, given its low molecular mass, hArc in water could not be
visualized with the electron microscope (Figure 5A). Heparin,
present at a final concentration up to 0.5 mg/ml, did not modify
the monomeric state (results not shown). However, when the
aqueous solution contained 20 mM sodium Hepes buffer, sparse
aggregation occurred (Figure 5B). The tendency of hArc to
aggregate in salt solution was readily observed by EM in buffer
with 125 mM KCl (Figure 5C).
Further visualization of the structural and oligomeric state of
recombinant hArc was performed by AFM (Figures 5D–5F). The
protein was deposited on a freshly cleaved mica surface, dried and
imaged. The images confirm that in buffer without salt at pH 7.4,
a combination of monodisperse and oliogomeric distribution of
hArc was obtained (Figures 5D–5F). We note that the diameter-to-
height profile of a protein imaged in a non-aqueous environment
may be subject to deformation and flattening by the cantilever tip
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Figure 4 Size distribution of hArc studied by DLS
hArc was prepared under various conditions at 22 μM. (A) Intensity size distribution of hArc in 10 mM potassium phosphate, pH 7.4, at 20◦C (orange), 36◦C (green) and 90◦C (blue) and in
distilled water at 36◦C (burgundy). Inset: volume size distribution of hArc at corresponding temperatures. (B) Thermal scans of hArc in 10 mM potassium phosphate at pH 6.8 (orange), pH 7.4
(green) and pH 8.2 (blue) and in distilled water (burgundy). (C) Effect of increasing temperature on Z-average diameter of hArc in 10 mM potassium phosphate, pH 7.4, without added salt (green),
with 150 mM KF (orange) and 300 mM KF (red). Inset: intensity size distribution of hArc under the same conditions at 36◦C. (D) Effect of temperature on Z-average diameter of hArc in 10 mM
potassium phosphate, pH 7.4 (green) or in the same buffer with either 150 mM KF (orange) or 50 μg/ml heparin (red) or both KF and heparin at the same concentrations (blue).
(Figure 5E). Nevertheless, the AFM images clearly showed hArc
to be pyramidal in shape in the monomeric state (Figures 5D–5F).
Binding of a presenilin-1 peptide
We also sought to confirm the functionality of recombinant
hArc by its ability to associate with PS1, a known Arc binding
partner. PS1 binds through its N-terminal region (residues 1–
40) within amino acid region 91–130 of hArc (Figure 1A) [14].
We investigated the binding of the N-terminal region of PS1
to recombinant hArc by SPR and CD (Figure 6). As seen by
SPR analyses, PS1 interacts with hArc. The sensorgrams for
PS1 binding at increasing peptide concentration are shown in
Figure 6A. The binding was concentration-dependent and resulted
in a Kd value of 42 +− 8 μM. Furthermore, as seen by comparing
the CD spectra for hArc and PS1, both separate and together, the
binding also induced a conformational change in the components
of the hArc–PS1 complex (Figure 6B).
DISCUSSION
Secondary and tertiary structure of hArc
In the present work, we propose a model for hArc as a
protein containing two domains with a large content of helical
structure on either side of a central, more disordered linker
region (Figure 7). A major chymotryptic cleavage site (Tyr172)
is located in the linker region (Figure 7A). CD analyses
confirmed high α-helical content in hArc (∼42%), whereas
thermal denaturation analyses displayed non-co-operative melting
indicating independent structural domains, each of which unfolds
at a different temperature (Tm values of ∼46 ◦C and ∼74 ◦C,
pH 7.4). Additional information on the thermal stability of the N-
terminal domain was obtained by DSF, which provided lower
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Figure 5 Visualization of hArc by EM and AFM
(A–C) EM analyses of hArc. Samples of hArc (15 μg/ml; 0.33 μM) were prepared in water (A), in 20 mM sodium Hepes, pH 7.4 (B) and in the same buffer with 125 mM KCl (C). (D–F) AFM images
of hArc. Samples were prepared in 10 mM potassium phosphate, pH 7.4, diffused on a mica surface. (D) Acquired height images of 2 μm, 500 nm and 200 nm scan sizes (from left to right). The
rectangles mark the close-up of the following panel. In the right close-up panel, small images with blue and green framing present the phase image of the protein shown in the height image above.
(E) Cross-section of the blue and green line in (D). (F) 3D representation of the 200 nm scan size image shown in (D).
Tm values than those obtained with thermal-dependent CD,
indicating that the loose 3D structure of hArc is less stable than
the secondary structure.
Several characteristics aided in the assignment of each thermal
transition to the respective N- and C-terminal domains. The
putative C-terminal domain is exceptionally well-conserved
(residues ∼209–365; 87.6% sequence identity; Figure 1B). We
therefore posit that this is the very stable domain (Tm ∼74 ◦C)
since evolutionary mutations, which favour protein stability, are
better conserved [39]. On the other hand, the N-terminal domain
(residues ∼25–130; 53.7% sequence identity), with a predicted
unbalanced charge distribution at neutral pH (pI = 9.6), shows a
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Figure 6 Interaction of PS1 with hArc
(A) SPR sensorgrams showing binding of the PS1 peptide (unbroken lines) to hArc with
increasing peptide concentrations (up to 400 μM) at 25◦C in HBS-EP, pH 7.4, buffer. A K d
value of 42 +− 8 μM was obtained from the analysis of the sensorgrams by fitting a 1:1 Langmuir
binding model. Peptide A (dashed line showing result at 400 μM) was used as a negative control
and showed very weak binding. (B) Far-UV CD spectra of hArc (green), PS1 (orange) and hArc
together with PS1 (red). The concentrations were 4 μM for hArc and 10 μM for PS1 and samples
were prepared in 10 mM potassium phosphate, pH 7.4. The CD spectra were taken at 20◦C and
are buffer-subtracted. The blue dashed line represents the arithmetic addition of the CD spectra
for hArc and PS1 alone.
lower stability (Tm ∼46 ◦C) and a concomitant stabilization by
higher pH. The interaction of this domain with the polyanion
heparin further supports these domain assignments and points to a
possible physiological significance of the interaction of hArc with
polyanions [40]. The interesting sequence identity with Marlin-1,
a microtubule-interacting protein implicated in protein trafficking
in neuronal dendrites [41,42], further supports that the basic N-
terminal domain of Arc may interact with polyanionic cytoskeletal
components (Figure 7B) in vivo. Arc has been shown to co-
sediment with F-actin but does not bind to monomeric actin [7].
During LTP in the dentate gyrus, Arc protein synthesis is required
to stabilize expansion of the F-actin network at synapses [17].
However, interactions between Arc and the actin cytoskeleton
are little understood. On the other hand, Arc has also been
suggested to interact with newly polymerized microtubules [22].
Figure 7 Putative modelled structure of hArc under different conditions
The structure of the basic N-terminal domain (blue), the middle linker region (green) and the
C-terminal domain (orange) corresponds to that of the models in Supplementary Figure S1. The
monomeric hArc at low ionic strength (A) and interacting with polyanions through the N-terminal
domain (B). (C) Dimeric hArc, formed through dimerization of the C-terminal domain. Further
tetramerization and oligomerization of hArc might occur following a similar arrangement of these
dimeric units as for spectrin [60].
Microtubule incursions into dendritic spines and the coupling of
microtubules to spine F-actin are important events in the structural
plasticity of dendritic spines [43,44].
Despite the high amount of observed (Figures 3A and 3B;
Supplementary Figures S3A and S3B) and predicted (Figure 1A;
Supplementary Figure S1) α-helical secondary structure in hArc,
hArc appears to be a flexible and modular protein, with loose
3D structure both within each domain and between domains
(Figure 7A). Thus, the thermal transitions are separated and non-
co-operative. The N-terminal domain is stabilized by heparin
binding as seen by the increased Tm for this domain, whereas
salt stabilizes the C-terminal domain (Table 1; also see the
next section), compatible with oligomerization. Furthermore,
stabilization of one domain leads to a concomitant decrease in the
corresponding Tm for the other domain, as measured by thermal-
dependent CD (Table 1), suggesting that the domains separate
upon their respective interactions (Figures 7B and 7C).
Monomeric/oligomeric hArc
Our biophysical investigations, EM micrographs and AFM
images led us to a monomeric model of hArc. The monomeric
species is favoured at low ionic strength, with a modular
disposition of the domains and scarce inter-domain interactions,
resulting in a pyramid-shaped protein (Figures 5D–5F; see
putative model in Figure 7A). The effect of salt on the stability
of the protein was remarkable. Salt increases the aggregation
propensity of hArc and it does so with a concomitant stabilization
of the C-terminal domain. Given the homology of the C-terminal
domain with α-spectrin repeats 21 and 22 [7,8] and the known
propensity of spectrin structural motifs to form dimers and
oligomers [45], we propose that the hArc C-terminal domain
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drives oligomerization (Figure 7C). Dimerization of coiled-coil
helical motifs of spectrin causes a substantial stabilization of
its structure, which may be imitated in hArc oligomerization
dynamics.
The reversible tendency of hArc to oligomerize at low
temperatures (∼4 ◦C–30 ◦C) illustrates the hydrophobic effect,
which seems to be crucial to both stabilize the C-terminal domain
and increase intermolecular interactions that could account for
hArc oligomerization, as described in other systems [46]. hArc
probably displays a propensity to aggregate at a temperature range
where most mesophilic proteins have maximum stability, around
17 ◦C [47].
Physiological consequences of Arc as a protein capable of
reversible self-association
Arc is able to interact with multiple protein partners and
is implicated in distinct neuronal mechanisms and forms of
synaptic plasticity. Its interaction with endophilin-3 and dynamin-
2 promotes internalization of AMPA-type glutamate receptors
[12]. During periods of synaptic inactivity, calcium/calmodulin-
dependent protein kinase II-β serves as an anchor for Arc in
dendritic spines, thereby ‘tagging’ specific synaptic populations
for the Arc-dependent clearance of AMPA-type glutamate
receptors [48]. The Arc partner PS1 is a core component of
the γ -secretase complex, which cleaves APP to generate the
pathological amyloid β-peptides(Aβs) in Alzheimer’s disease.
Arc interaction with PS1 causes an increase in APP endocytosis,
thereby promoting Aβ formation and accumulation [14]. In the
present study, we find that binding of PS1 peptide results in
structural changes of the peptide–protein complex, as measured by
CD and SPR. PS1 binds at the interphase between the N-terminal
domain and the disordered central region, whereas dynamin-2
binds Arc residues 195–214 [12], at the interphase between the
central region and the second domain. Highly-connected hub
proteins have been shown to have more observed and predicted
disordered regions [49]. Disordered regions can enhance protein
turnover in the absence of a ligand [50], increase the speed of
interactions [51] and enhance overall flexibility and folding [52].
A flexible linker region between the two elongated hArc domains
may allow them to move freely with respect to each other and
confer the recognition of, and binding to, multiple targets. This
disordered region may therefore be central in regulating Arc
protein–protein interactions.
Evidence suggests that hArc is a flexible hub protein capable
of interacting with diverse protein effectors. Hub proteins such
as hArc have been reported to play essential roles in cellular
regulation and tend to be highly conserved across species
[53]. AFM and EM images of hArc show both monomeric
and oligomeric formations pointing to possible coexistence of
multiple pools of Arc in the cell, with distinct functional
capabilities and rates of degradation. Self-oligomerization of
hArc may serve as a hub to spatially concentrate protein
partners within neuronal sub-compartments (e.g. dendritic spines
or nuclear domains). During LTP consolidation in the dentate
gyrus, Arc synthesis serves to promote cofilin phosphorylation
and actin cytoskeletal reorganization at synapses. This appears
to be a highly dynamic process dependent on the sustained
rapid synthesis and degradation of Arc protein [17,19,54,55].
As oligomers are expected to have slow turnover, it is likely
that the fast actions of Arc of the order of minutes depend on
the monomeric form. However, further work is needed to more
clearly identify and characterize the precise roles of monomeric
and oligomeric Arc protein.
The polymorphic variant V231G hArc
A single polymorphism can have profound effects on protein
structure and/or function. Only one known missense variation
occurs in the hArc protein (rs201562490; V231G) and it has
previously not been characterized. We analysed the V231G
polymorphism with regard to structure and stability and observed
only slight changes in secondary structure content for V231G
hArc. This particular variation occurs in 2–4.6% of the
population, so a profound deleterious or even beneficial phenotype
is unlikely as it would have been uncovered. Thus, the lack of
dramatic changes in stability is as expected. However, further
studies are necessary to investigate whether the polymorphism
whether alters the binding affinity of various partners and/or
regulates Arc’s response to various cytosolic environments.
In conclusion, the present study elucidates basic physicochemical
and structural properties of hArc. The findings are important for
the elucidation of the molecular function of Arc as a master
regulator of activity-dependent synaptic plasticity and brain
adaptive mechanisms, including memory formation. Moreover,
the work paves the way for in-depth crystallographic analysis of
the hArc protein structure.
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